MicroRNA-19a Targets Fibroblast Growth Factor-Inducible Molecule 14 and Prevents Tubular Damage in Septic AKI

Area of Science:

• Molecular Biology
• Renal Pathophysiology
• Microbiology

Background:

• Septic acute kidney injury (AKI) involves tubular damage, with Fibroblast growth factor-inducible molecule 14 (Fn14) playing a key role.
• Understanding the regulatory mechanisms of Fn14 in septic AKI is crucial for developing effective treatments.

Purpose of the Study:

• To elucidate the mechanism of Fn14 deregulation in septic AKI.
• To investigate the role of microRNA-19a (miR-19a) in regulating Fn14 expression and its impact on tubular apoptosis.

Main Methods:

• Identification of Fn14 as a direct target of miR-19a using 3' UTR binding assays.
• Assessment of miR-19a's effect on lipopolysaccharide (LPS)-induced tubular cell apoptosis in vitro and in vivo.
• Genetic ablation studies of Fn14 and cylindromatosis (CYLD) in mouse models of septic AKI.

Main Results:

• miR-19a directly binds to the 3' UTR of Fn14, repressing its expression independently of CYLD.
• Genetic deletion of Fn14, but not CYLD, abrogated miR-19a's protective effect against LPS-induced tubular apoptosis.
• Systemic delivery of miR-19a demonstrated protective effects against experimental septic AKI in mice.

Conclusions:

• miR-19a acts as a negative regulator of Fn14 in the context of septic AKI.
• miR-19a antagonizes LPS-induced tubular apoptosis by targeting Fn14.
• miR-19a represents a potential therapeutic strategy for preventing and treating septic AKI.